Back
Innate Pharma SA Vs. Impinj Industry Stock Comparison
Buy
63
IPHA
Innate Pharma SA
Last Price:
$2.27
Seasonality Move:
-9.96%
Buy
56
PI
Impinj
Last Price:
$111.91
Seasonality Move:
14.66%
Buy
63
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.44. The Score for IPHA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.44The current trend is moderately bullish and IPHA is experiencing slight selling pressure.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 73.75 | Buy |
Chaikin Money Flow: | 2973 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
PI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.42 | Buy |
Relative Strength Index (14 RSI): | 65.44 | Buy |
Chaikin Money Flow: | -245432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.3 | Buy |
20-day SMA: | 2.11 | Buy |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2 | Buy |
8-day EMA: | 2.3 | Buy |
20-day EMA: | 2.16 | Buy |
50-day EMA: | 2.05 | Buy |
200-day EMA: | 2.06 | Buy |
PI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.04 | Buy |
20-day SMA: | 84.75 | Buy |
50-day SMA: | 86.47 | Buy |
200-day SMA: | 147.06 | Sell |
8-day EMA: | 96 | Buy |
20-day EMA: | 89.91 | Buy |
50-day EMA: | 92.57 | Buy |
200-day EMA: | 125.54 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Impinj Earnings Growth & PI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.55 per share, a decrease this year of $0.46 per share, and an increase next year of $0.89 per share.
Innate Pharma SA Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Impinj Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |